Moleculin Biotech, Inc.
MBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,399 | -$7,640 | -$6,436 | -$1,882 |
| Dep. & Amort. | $21 | $28 | $31 | $31 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $417 | $485 | $0 |
| Change in WC | -$1,695 | -$335 | $706 | $1,046 |
| Other Non-Cash | $19,850 | $1,948 | $650 | -$4,278 |
| Operating Cash Flow | -$7,223 | -$5,582 | -$4,564 | -$5,083 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,375 | $5,417 | $7,995 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $6 | $4 | $0 |
| Financing Cash Flow | $6,375 | $5,423 | $7,999 | $1 |
| Forex Effect | -$6 | $0 | $3 | -$45 |
| Net Chg. in Cash | -$854 | -$159 | $3,438 | -$5,127 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,557 | $7,716 | $4,278 | $9,405 |
| End Cash | $6,703 | $7,557 | $7,716 | $4,278 |
| Free Cash Flow | -$7,223 | -$5,582 | -$4,564 | -$5,083 |